Activation of HSCs drives hepatic fibrosis, and is inhibited by peroxisome proliferator-activated receptor gamma (PPARγ) signalling, in part through antagonism of Wnt activity.5 This evidence concerns the gene PPARG and Hepatic fibrosis.